ORESTI, SARA

ORESTI, SARA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review 2023 Agostara, Alberto GiuseppeRoazzi, LauraPiscazzi, DanieleMartinelli, FrancescaCiarlo, GabrieleOresti, SaraSartore-Bianchi, AndreaSiena, SalvatorePizzutilo, Elio Gregory + Article (author) -
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity 2023 Elio Gregory. PizzutiloLaura RoazziAlberto Giuseppe. AgostaraSara OrestiSalvatore SienaAndrea Sartore-Bianchi + Article (author) -
Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO) 2022 E. G. PizzutiloA. G. AgostaraS. OrestiL. MazzeoT. BeninatoG. CereaA. Sartore-BianchiS. Siena + Conference Object -
Activity of OsimeRTInib in NSCLC with UNcommon EGFR Mutations: Retrospective observational multicenter study (ARTICUNO) 2022 E. G. PizzutiloG. CereaS. OrestiA. G. AgostaraL. MazzeoD. L. CortinovisA. Sartore BianchiS. Siena + Conference Object -
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 2022 Zattarin E.Oresti S.Pizzutilo E. G. + Article (author) -